1887

Abstract

We present a case of olecranon bursitis in a woman with known immunosuppression secondary to the treatment received for her Behçet's disease. We found only one other case report of olecranon bursitis caused by in the literature, which, unlike our case, presented in an immunocompetent adult following trauma. This case extends the range of opportunistic mycobacterial infections that are associated with anti-tumour necrosis factor therapy.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.006809-0
2009-03-01
2019-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/3/371.html?itemId=/content/journal/jmm/10.1099/jmm.0.006809-0&mimeType=html&fmt=ahah

References

  1. ATS ( 1997; ). Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156, S1–S25.[CrossRef]
    [Google Scholar]
  2. Barham, G. S. & Hargreaves, D. G. ( 2006; ). Mycobacterium kansasii olecranon bursitis. J Med Microbiol 55, 1745–1746.[CrossRef]
    [Google Scholar]
  3. Boulman, N., Rozenbaum, M., Slobodin, G. & Rosner, I. ( 2006; ). Mycobacterium fortuitum infection complicating infliximab therapy in rheumatoid arthritis. Clin Exp Rheumatol 24, 723
    [Google Scholar]
  4. BTS ( 2000; ). Management of opportunistic mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 55, 210–218.[CrossRef]
    [Google Scholar]
  5. Chang, J. & Girgis, L. ( 2007; ). Clinical use of anti-TNF-α biological agents – a guide for GPs. Aust Fam Physician 36, 1035–1038.
    [Google Scholar]
  6. Dawson, D. J., Blacklock, Z. M., Ashdown, L. R. & Botteger, E. C. ( 1995; ). Mycobacterium asiaticum as the probable causative agent in a case of olecranon bursitis. J Clin Microbiol 33, 1042–1043.
    [Google Scholar]
  7. Fallon, J. C., Patchett, S., Gulmann, C. & Murphy, G. M. ( 2008; ). Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab. Clin Exp Dermatol 33, 43–45.
    [Google Scholar]
  8. Friedman, N. D. & Sexton, D. J. ( 2001; ). Bursitis due to Mycobacterium goodii, a recently described, rapidly growing mycobacterium. J Clin Microbiol 39, 404–405.[CrossRef]
    [Google Scholar]
  9. Maloney, J. M., Gregg, C. R., Stephens, D. S., Manian, F. A. & Rimland, D. ( 1987; ). Infections by Mycobacterium szulgai in humans. Rev Infect Dis 9, 1120–1126.[CrossRef]
    [Google Scholar]
  10. Marie, I., Heliot, P., Roussel, F., Hervé, F., Muir, J. F. & Levesque, H. ( 2005; ). Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab. Rheumatology 44, 1201–1202.[CrossRef]
    [Google Scholar]
  11. Martín-Aspas, A., Guerro-Sánchez, F., García-Martos, P., González-Moya, E., Medina-Varo, F. & Girón González, J. A. ( 2008; ). Bilateral pneumonia by Mycobacterium aurum in a patient receiving infliximab therapy. J Infect 57, 167–169.[CrossRef]
    [Google Scholar]
  12. Mufti, A. H., Toye, B. W., Mckendry, R. R. & Angel, J. B. ( 2005; ). Mycobacterium abscessus infection after use of tumour necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumour necrosis factor alpha inhibitor use. Diagn Microbiol Infect Dis 53, 233–238.[CrossRef]
    [Google Scholar]
  13. Okubo, H., Iwamoto, M., Yoshio, T., Okazaki, H., Kato, T., Bandoh, M. & Minota, S. ( 2005; ). Rapidly aggravated Mycobacterium avium infection in a patient with rheumatoid arthritis treated with infliximab. Mod Rheumatol 15, 62–64.[CrossRef]
    [Google Scholar]
  14. Rallis, E., Koumantaki-Mathioudaki, E., Frangoulis, E., Chatziolou, E. & Katsambas, A. ( 2007; ). Severe sporotrichoid fish tank granuloma following infliximab therapy. Am J Clin Dermatol 8, 385–388.[CrossRef]
    [Google Scholar]
  15. Rutten, M. J., Van der Berg, J. C., Van der Hoogen, F. H. & Lemmens, J. A. ( 1998; ). Non-tuberculous mycobacterial bursitis and arthritis of the shoulder. Skeletal Radiol 27, 33–35.[CrossRef]
    [Google Scholar]
  16. Salvana, E. M. T., Cooper, G. S. & Salata, R. A. ( 2007; ). Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J Infect 55, 484–487.[CrossRef]
    [Google Scholar]
  17. Slifman, N. R., Gershon, S. K., Lee, J. H., Edwards, E. T. & Braun, M. M. ( 2003; ). Listeria monocytogenes infection as a complication of treatment with tumour necrosis factor α-neutralizing agents. Arthritis Rheum 48, 319–324.[CrossRef]
    [Google Scholar]
  18. Weinstein, P. S., Canoso, J. J. & Wohlgethan, J. R. ( 1984; ). Long-term follow-up of corticosteroid injection for traumatic olecranon bursitis. Ann Rheum Dis 43, 44–46.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.006809-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error